Fig. 4

Overall survival by prognostic score. The five risk factors correlating independently with shorter survival were non-matched therapy (1 point), performance status > 1 (2 points), liver metastases (1 point), LDH levels > upper limit of normal (1 point), and PI3K/Akt/mTOR pathway alterations (1 point)